Keefe Bruyette raised the firm’s price target on Corebridge (CRBG) to $39 from $37 and keeps an Outperform rating on the shares. The firm is assuming “normal” Q2 equity market appreciation of 2% for life insurance companies, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBG:
- Corebridge Financial Reports Q1 2025 Earnings
- Corebridge Financial’s Resilient Q1 Earnings Call Insights
- Corebridge price target raised to $35 from $34 at BofA
- Corebridge Financial, Inc.: Strong Growth Potential and Shareholder Value Despite Challenges
- Corebridge price target raised to $38 from $36 at Barclays